Maureen Beresini, Senior Scientist at Genentech, will present on "From HTS to Mechanism: Kinase Screening Strategies That Maximize Hit Value" at the 8th Protein Kinases in Drug Discovery Conference on July 8-9, 2013 in Boston.
Susan Lindquist, Professor of Biology and Member of Whitehead Institute at MIT, will give a keynote presentation on "Hsp90 as a Sensor for In Vivo Drug: Target Interactions" at the 8th Protein Kinases in Drug Discovery Conference on July 8-9, 2013 in Boston, MA.
Malcolm Moos, Medical Officer of Cellular,Tissue and Gene Therapies at the Center for Biologics Evaluation and Research of FDA will present at the Stem Cell Summit 2013 on April 29-30, 2013 in Boston, MA.
Gregory Bonfiglio from Proteus Venture Partners, will give a presentation on "Funding for Regenerative Medicine Technologies: Opportunities And Challenges" at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA)
Yi Zhang, HHMI Investigator and Senior Investigator of the Program of Cellular & Molecular Medicine at Boston Children's Hospital and a Professor of Genetics and of Pediatrics at Harvard Medical School will speak on the "Mechanism and Function of Tet-mediated 5mC Oxidation" at the 3rd Epigenetics in Drug Discovery Conference on May 8-10, 2013 in Boston, MA.
Mostafa Ronaghi, Senior Vice President and Chief Technology Officer of Illumina Will Give a Keynote Presentation on "The New Era of Medicine Enabled by Advancing NextGen Sequencing" at GTC's 3rd Next Generation Sequencing Conference on June 20-21, 2013 in San Francisco, CA
Elona Baum, General Counsel & Vice President of Business Development at CIRM to Present at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA)
Peter Lee, Professor and Associate Chair of Cancer Immunotherapeutics and Tumor Immunology (CITI) at City of Hope and Beckman Research Institute Beckman Center, will speak on "Immune Cells in Tumor-Draining Lymph Nodes: Novel Prognostic Indicators for Breast Cancer" at the 6th Imaging in Drug Discovery and Development Conference (May 8-10, 2013 in Boston, MA)
PREMIER Biosoft, a leading bioinformatics company, adds strength to its mass spectrometry product portfolio with the acquisition of ProteoIQ, a comprehensive tool for comparative and quantitative proteomics, from NuSep, Australia.
George Weinstock, Leader of the Human Microbiome Project and Professor of Genetics and Molecular Microbiology at Washington University at St. Louis, Will Give a Keynote Presentation on "The Microbiome, Infectious Diseases, and NGS" at GTC's 3rd Next Generation Sequencing Conference on June 19-21, 2013 in San Francisco, CA
Protein Signal now offers a Mouse Anti-PEG Monoclonal Antibody , a new member of THETM Elite series, which represents THE best quality antibody in the industry.
Riccardo Perfetti, Vice President of Global Medical Affairs Diabetes Division at Sanofi To Give a Keynote Presentation on "The Most Recent ADA/EASD Guidelines Are Changing the Development Strategies: A Focus Combination Therapy for the Treatment of Diabetes" at Diabetes Summit 2013 in Boston, MA on April 29-30.
Douglas A. Melton, Investigator at Howard Hughes Medical Institute, Thomas Dudley Cabot Professor at Harvard University and Co-Director of Harvard's Stem Cell Institute to Give a Keynote Presentation at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston)
Rudolf Jaenisch, Founding Member of The Whitehead Institute and Professor of Biology at the Massachusetts Institute of Technology to Give a Plenary Keynote Presentation at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston)
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods.
Barbara Wirostko, Chief Scientific Officer and Co-Founder of Jade Therapeutics and Clinical Adjunct Associate Professor of Ophthalmology at University of Utah To Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA).
Gary Novack, President at PharmaLogic Development To Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA).
Peter Adamson, Vice President and Head of Research and Ophthalmology at GlaxoSmithKline To Give a Featured Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA)
Samir Patel, President and CEO at Ophthotech To Give a Keynote Presentation at the 5th Ocular Diseases & Drug Development Conference (March 21-22, 2013 in San Francisco, CA).
Michael Pellini, President and CEO of Foundation Medicine, Will Be Presenting at GTC's 6th Oncology Biomarkers Conference, Taking Place in San Francisco, CA on March 20-22, 2013.
Ian Ahnfelt-Ronne, Corporate Vice President at Novo Nordisk A/S Will Give a Featured Presentation at the 11th Cytokines and Inflammation Conference (Jan 31-Feb 1, 2013 in San Diego, CA)
Tomas Mustelin, Vice President of Research, Respiratory, Inflammatory, and Autoimmune Diseases at MedImmune Will Give a Featured Presentation at the 11th Cytokines and Inflammation Conference (Jan 31-Feb 1, 2013 in San Diego, CA).
Daniel Chan, Professor and Director of Clinical Chemistry Division at John Hopkins University Will Give a Plenary Keynote Presentation at GTC's Biomarker Summit 2013 Taking Place in San Francisco, CA on March 20-22, 2013.
Howard A. Young, Principal Investigator of the Cancer and Inflammation Program at the Frederick National Laboratory for Cancer Research Will Give a Featured Presentation at the 11th Cytokines and Inflammation Conference (Jan 31-Feb 1, 2013 in San Diego, CA).
Joost J. Oppenheim, Chief of Laboratory of Molecular Immunoregulation at NCI, NIH Will Give a Featured Presentation at the 11th Cytokines and Inflammation Conference (Jan 31-Feb 1, 2013 in San Diego, CA)
CelKine is a dedicated sub-brand of GenScript USA relating cytokine business and products. CelKine's website, (www.celkine.com), has been officially launched today. Customers can now order cytokine products online quickly and easily.
IL-33 as a Target for Asthma and COPD will be Presented by Dirk Smith from Amgen and Roland Kolbeck from MedImmune at GTC's 2nd Allergy Research & Drug Discovery Conference Taking Place in San Diego, CA on January 31st - February 1st, 2013.
"Achieving Hospital-Physician Physician Alignment," an issue facing healthcare leadership, is also a topic for discussion at the Bariatric Centers Executive Leadership Conference, November 8-9, 2012 in Boston, MA.
Harsukh Parmar, Vice President & Global Head of Translational & Experimental Medicine, Inflammation at Roche will give a plenary keynote presentation at the 8th Modern Drug Discovery & Development Summit (October 24-26, 2012 in Philadelphia, PA).
Anthony J. Coyle, Vice President and Chief Scientific Officer of Centers for Therapeutic Innovation at Pfizer Will Give a Plenary Keynote Presentation at the 8th Modern Drug Discovery & Development Summit (October 24-26, 2012 in Philadelphia, PA).
